![](/img/cover-not-exists.png)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes
Lebenthal,, Brener,, Hershkovitz,, Shehadeh,, Shalitin,, Lewis,, Elias,, Haim,, Barash,, Loewenthal,, Zuckerman-Levin,, Stein,, Tov,, Rachmiel,Volume:
20
Journal:
International Journal of Molecular Sciences
DOI:
10.3390/ijms20236032
Date:
November, 2019
File:
PDF, 2.15 MB
2019